Recruiting

Vitamin C

Sponsor:

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Code:

NCT05555576

Conditions

Pain, Acute

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vitamin C

Placebo

Study Details

Brief summary:

Recent evidence has shown that vitamin C has some analgesic properties and can therefore reduce opioids used during healing. Vitamin C analgesic effect has been explored mostly during the short-term postoperative context or in disease specific chronic pain prevention but not after acute musculoskeletal injuries, which are often seen in the emergency department (ED).

The study's primary aim is to compare the total morphine 5 mg equivalent pills consumed during a two-week follow-up between patients receiving vitamin C or a placebo after ED discharge for an acute musculoskeletal pain complaint.

The investigators will conduct a double-blind randomized placebo-controlled trial with 464 participants distributed in two arms, one group receiving 1 000 mg of vitamin C twice a day for 14 days and another one receiving a placebo. Participants will be ≥18 years of age, treated in ED for acute musculoskeletal pain present for less than 2 weeks, and discharged with an opioid prescription for home pain management. Total morphine 5 mg equivalent pills consumed during the two-week follow-up will be assessed via an electronic (or paper) diary. In addition, patients will report their daily pain intensity, pain relief, side effects, and other types of pain medication or other non-pharmacological approach (ice, heat, immobilization, etc.) used. Three months after the injury, participants will also be contacted to evaluate chronic pain development. The investigators hypothesized that vitamin C, compared to a placebo, will reduce opioid consumption during a 14-day follow-up for ED discharged patients treated for acute pain.

Conditions

Pain, Acute

Study ID

NCT05555576

Start date

Nov 1, 2023

Status verified date

May, 2025

Completion date

Dec, 2026

Anticipated

Primary completion date

Jun, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Aged 18 and over;
2. Treated in ED for acute musculoskeletal pain present for less than 2 weeks;
3. Discharged with an opioid prescription;
4. Speaks French or English.

Exclusion Criteria:

1. Opioid use 1 month prior to the ED visit;
2. Already taking vitamin C supplement;
3. Active cancer;
4. Treated for chronic pain;
5. Treated for opioid use disorder;
6. Unable to fill out diary or unavailable for follow-up;
7. Any allergy, intolerance or sensitivity to milk (lactose) or morphine
8. Treated with cyclosporin or coumadin
9. Pregnant or lactating (dosage > 1,800 mg not recommended. For women of child-bearing age and sexually active in the past 3 months, a urine pregnancy test will be performed.)

Study Design

Enrollment

464 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Basic Science

Interventions and Outcome Measures

Arms

experimental: Vitamin C

1 000 mg vitamin C taken orally twice a day

placebo comparator: Placebo

Matching placebo

Interventions

Vitamin C

1000 mg vitamin C taken orally twice a day (one in the morning and one in the evening) for a 14-day period after ED discharge for the treatment arm

Placebo

Placebo taken orally twice a day (one in the morning and one in the evening) for a 14-day period after ED discharge for the treatment arm

Primary outcome measure

  • Difference in the total morphine 5 mg equivalent pills consumed [ Time Frame: 14 days ]

Central Contacts and Locations

Central contacts

Locations

Hôpital du Sacré-Coeur de Montréal

Recruiting

Montreal, Quebec, Canada, H4J 1C4

More Information

Sponsor

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Last update posted

Mar 31, 2026

Last verified

May, 2025

Keywords

  • Vitamin C
  • Opioids
  • Emergency department
  • Pain

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal on 2026-03-31.